Point72 Asset Management »

Candel Therapeutics shares owned by Point72 Asset Management

Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by Point72 Asset Management from 13F filings

Historical chart of Point72 Asset Management investment in Candel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Candel Therapeutics held by Point72 Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Candel Therapeutics by Point72 Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $525k 107k 4.90
2022-09-30 $1.3M 403k 3.14
2022-06-30 $2.4M 743k 3.24

More positions owned by Point72 Asset Management

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Arista Networks Com Shs (ANET)
Asml Hldg Nv N Y Registry Shs (ASML)
Broadcom (AVGO)
Credo Technology Group Holdi Ordinary Shares (CRDO)
Teradyne (TER)
Meta Platforms Cl A (META)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Applied Materials (AMAT)
Spotify Technology S A SHS (SPOT)
Equinix (EQIX)
Home Depot (HD)

View all positions for Point72 Asset Management

Top funds holding Candel Therapeutics

FMR
BlackRock
Portolan Capital Management
Acorn Capital Advisors
Vanguard Capital Management
Vanguard Group
Vestal Point Capital
Millennium Management
Geode Capital Management
Halter Ferguson Financial
State Street Corporation
Sands Capital Ventures
Northern Trust
Vanguard Fiduciary Trust
Vanguard Portfolio Management

View all funds holding Candel Therapeutics